Literature DB >> 34001972

A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells.

Xiaojing Yang1, Jina Nanayakkara1, Duncan Claypool2, Sadegh Saghafinia3, Justin J M Wong1, Minqi Xu1, Xiantao Wang2, Christopher J B Nicol4,5, Iacovos P Michael3, Markus Hafner2, Xiaolong Yang6, Neil Renwick7.   

Abstract

Lung carcinoids are variably aggressive and mechanistically understudied neuroendocrine neoplasms (NENs). Here, we identified and elucidated the function of a miR-375/yes-associated protein (YAP) axis in lung carcinoid (H727) cells. miR-375 and YAP are respectively high and low expressed in wild-type H727 cells. Following lentiviral CRISPR/Cas9-mediated miR-375 depletion, we identified distinct transcriptomic changes including dramatic YAP upregulation. We also observed a significant decrease in neuroendocrine differentiation and substantial reductions in cell proliferation, transformation, and tumor growth in cell culture and xenograft mouse disease models. Similarly, YAP overexpression resulted in distinct and partially overlapping transcriptomic changes, phenocopying the effects of miR-375 depletion in the same models as above. Transient YAP knockdown in miR-375-depleted cells reversed the effects of miR-375 on neuroendocrine differentiation and cell proliferation. Pathways analysis and confirmatory real-time PCR studies of shared dysregulated target genes indicate that this axis controls neuroendocrine related functions such as neural differentiation, exocytosis, and secretion. Taken together, we provide compelling evidence that a miR-375/YAP axis is a critical mediator of neuroendocrine differentiation and tumorigenesis in lung carcinoid cells.

Entities:  

Year:  2021        PMID: 34001972     DOI: 10.1038/s41598-021-89855-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

Review 1.  Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management.

Authors:  Talal Hilal
Journal:  Ther Adv Med Oncol       Date:  2016-11-17       Impact factor: 8.168

Review 2.  Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.

Authors:  Andrew E Hendifar; Alberto M Marchevsky; Richard Tuli
Journal:  J Thorac Oncol       Date:  2016-11-24       Impact factor: 15.609

Review 3.  Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.

Authors:  Patrick Robelin; Julien Hadoux; Julien Forestier; David Planchard; Valérie Hervieu; Amandine Berdelou; Jean-Yves Scoazec; Pierre-Jean Valette; Sophie Leboulleux; Michel Ducreux; Catherine Lombard-Bohas; Eric Baudin; Thomas Walter
Journal:  J Thorac Oncol       Date:  2019-02-13       Impact factor: 15.609

4.  miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.

Authors:  Eri Nishikawa; Hirotaka Osada; Yasumasa Okazaki; Chinatsu Arima; Shuta Tomida; Yoshio Tatematsu; Ayumu Taguchi; Yukako Shimada; Kiyoshi Yanagisawa; Yasushi Yatabe; Shinya Toyokuni; Yoshitaka Sekido; Takashi Takahashi
Journal:  Cancer Res       Date:  2011-08-19       Impact factor: 12.701

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 6.  MicroRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Hoell; Pavel Morozov; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 7.  New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

Authors:  Jules L Derks; Noémie Leblay; Sylvie Lantuejoul; Anne-Marie C Dingemans; Ernst-Jan M Speel; Lynnette Fernandez-Cuesta
Journal:  J Thorac Oncol       Date:  2018-02-14       Impact factor: 15.609

Review 8.  The role of MicroRNAs in human cancer.

Authors:  Yong Peng; Carlo M Croce
Journal:  Signal Transduct Target Ther       Date:  2016-01-28

Review 9.  Systemic treatment for lung carcinoids: from bench to bedside.

Authors:  Mariangela Torniai; Laura Scortichini; Francesca Tronconi; Corrado Rubini; Francesca Morgese; Silvia Rinaldi; Paola Mazzanti; Rossana Berardi
Journal:  Clin Transl Med       Date:  2019-07-04

10.  A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.

Authors:  Iacovos P Michael; Sadegh Saghafinia; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-08       Impact factor: 11.205

View more
  2 in total

1.  Intermittent Hypoxia Increased the Expression of DBH and PNMT in Neuroblastoma Cells via MicroRNA-375-Mediated Mechanism.

Authors:  Shin Takasawa; Ryogo Shobatake; Yoshinori Takeda; Tomoko Uchiyama; Akiyo Yamauchi; Mai Makino; Sumiyo Sakuramoto-Tsuchida; Keito Asai; Hiroyo Ota; Asako Itaya-Hironaka
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

2.  Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC).

Authors:  Xujie Sun; Jinyao Zhang; Jiyan Dong; Li Liu; Xue Li; Puyuan Xing; Jianming Ying; Yiqun Che; Junling Li; Lin Yang
Journal:  Transl Oncol       Date:  2022-09-11       Impact factor: 4.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.